Asian Pacific Journal of Cancer Prevention

  • 제14권11호
  • /
  • Pages.6245-6248
  • /
  • 2013
  • /
  • 1513-7368(pISSN)
  • /
  • 2476-762X(eISSN)
아시아태평양암예방학회 (Asian Pacific Journal of Cancer Prevention)
권호 표지
DOI QR코드

DOI QR Code

Effects of PTTG Down-regulation on Proliferation and Metastasis of the SCL-1 Cutaneous Squamous Cell Carcinoma Cell Line

  • Xia, Yong-Hua (Department of Dermatovenereology, the First Affiliated Hospital of Xinxiang Medical University) ;
  • Li, Min (Department of Dermatovenereology, the First Affiliated Hospital of Xinxiang Medical University) ;
  • Fu, Dan-Dan (Department of Dermatovenereology, the First Affiliated Hospital of Xinxiang Medical University) ;
  • Xu, Su-Ling (Department of Oncology, the First Affiliated Hospital of Xinxiang Medical University) ;
  • Li, Zhan-Guo (Department of Dermatovenereology, the First Affiliated Hospital of Xinxiang Medical University) ;
  • Liu, Dong (Department of Dermatovenereology, the First Affiliated Hospital of Xinxiang Medical University) ;
  • Tian, Zhong-Wei (Department of Dermatovenereology, the First Affiliated Hospital of Xinxiang Medical University)
  • 발행 : 2013.11.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Aims: To study effects of down-regulation of pituitary tumor-transforming gene (PTTG) on proliferation and metastasis ability of the SCL-1 cutaneous squamous cell carcinoma (CSCC) cell line and explore related mechanisms. Methods: SCL-1 cells were divided into 3 groups (untreated, siRNA control and PTTG siRNA). Cell proliferation assays were performed using a CCK-8 kit and proliferation and metastasis ability were analyzed using Boyden chambers. In addition, expression of MMP-2 and MMP-9 was detected by r-time qPCR and Western blotting. Results: Down-regulation of PTTG could markedly inhibit cell proliferation in SCL-1 cells, compared to untreated and control siRNA groups (P < 0.05). Real-time qPCR demonstrated that expression levels of PTTG, MMP-2 and MMP-9 in the PTTG siRNA group were 0.8%, 23.2% and 21.3% of untreated levels. Western blotting revealed that expression of PTTG, MMP-2 and MMP-9 proteins in the PTTG siRNA group was obviously down-regulated. The numbers of migrating cells ($51.38{\pm}4.71$) in the PTTG siRNA group was obviously lower than that in untreated group ($131.33{\pm}6.12$) and the control siRNA group ($127.72{\pm}5.20$) (P < 0.05), suggesting that decrease of proliferation and metastasis ability mediated by PTTG knock-down may be closely correlated with down-regulation of MMP-2 and MMP-9 expression. Conclusion: Inhibition of PTTG expression may be a new target for therapy of CSCC.

키워드

참고문헌

  1. Akino K, Akita S, Mizuguchi T, et al (2005). A novel molecular marker of pituitary tumor transforming gene involves in a rat liver regeneration. J Surg Res, 129, 142-6. https://doi.org/10.1016/j.jss.2005.04.019
  2. Bhave SL, Teknos TNPan Q (2011). Molecular parameters of head and neck cancer metastasis. Crit Rev Eukaryot Gene Expr, 21, 143. https://doi.org/10.1615/CritRevEukarGeneExpr.v21.i2.40
  3. Bogusiewicz M, Stryjecka-Zimmer M, Szymanski M, et al (2003). Activity of matrix metalloproteinases-2 and -9 in advanced laryngeal cancer. Otolaryngol Head Neck Surg, 2003, 132-6.
  4. Chen G, Li J, Li F, et al (2004). Inhibitory effects of anti-sense pttg on malignant phenotype of human ovarian carcinoma cell line sk-ov-3. J Huazhong Univ Sci Technolog Med Sci, 24, 369-72.(In Chinease) https://doi.org/10.1007/BF02861870
  5. Chollet A, Hohl D, Perrier P (2012). Risk of cutaneous squamous cell carcinomas: The role of clinical and pathological reports]. Rev Med Suisse, 8, 743.
  6. Coussens LM, Tinkle CL, Hanahan D, et al (2000). Mmp-9 supplied by bone marrow.derived cells contributes to skin carcinogenesis. Cell, 103, 481-90. https://doi.org/10.1016/S0092-8674(00)00139-2
  7. Fang J, Shing Y, Wiederschain D, et al (2000). Matrix metalloproteinase-2 is required for the switch to the angiogenic phenotype in a tumor model. Proc Ncad Sci USA, 97, 3884-9. https://doi.org/10.1073/pnas.97.8.3884
  8. Franchi A, Santucci M, Masini E, et al (2002). Expression of matrix metalloproteinase 1, matrix metalloproteinase 2, and matrix metalloproteinase 9 in carcinoma of the head and neck. Cancer, 95, 1902-10. https://doi.org/10.1002/cncr.10916
  9. Gelse K, Poschl E, Aigner T (2003). Collagens-structure, function, and biosynthesis. Adv Drug Deliv Rev, 55, 1531-46. https://doi.org/10.1016/j.addr.2003.08.002
  10. Geneva, Switzerland: World Health Organization. Too Much Fun in the Sun Dangerous; Press Release WHO/40; 3 August 1999. http://www.who.int/inf-pr-1999/en/pr99-40.html
  11. Goh RY, Bova R, Fogarty GB (2012). Cutaneous squamous cell carcinoma metastatic to parotid-analysis of prognostic factors and treatment outcome. World J Surg Oncol, 10, 1-5. https://doi.org/10.1186/1477-7819-10-1
  12. Itoh Y, Nagase H (2002). Matrix metalloproteinases in cancer. Essays Biochem, 38, 21-36. https://doi.org/10.1042/bse0380021
  13. Jung CR, Yoo J, Jang YJ, et al (2006). Adenovirus-mediated transfer of sirna against pttg1 inhibits liver cancer cell growth in vitro and in vivo. Hepatology, 43, 1042-52. https://doi.org/10.1002/hep.21137
  14. Kakar SS, Malik MT (2006). Suppression of lung cancer with sirna targeting pttg. Int J Oncol, 29, 387.
  15. Kessenbrock K, Plaks V, Werb Z (2010). Matrix metalloproteinases: Regulators of the tumor microenvironment. Cell, 141, 52-67. https://doi.org/10.1016/j.cell.2010.03.015
  16. Livak KJ, Schmittgen TD (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods, 25, 402-8. https://doi.org/10.1006/meth.2001.1262
  17. London CA, Sekhon HS, Arora V, et al (2003). A novel antisense inhibitor of MMP-9 attenuates angiogenesis, human prostate cancer cell invasion and tumorigenicity. Cancer Gene Ther, 10, 823-32. https://doi.org/10.1038/sj.cgt.7700642
  18. Moore BA, Weber RS, Prieto V, et al (2005). Lymph node metastases from cutaneous squamous cell carcinoma of the head and neck. Laryngoscope, 115, 1561-7. https://doi.org/10.1097/01.mlg.0000173202.56739.9f
  19. Mourouzis C, Boynton A, Grant J, et al (2009). Cutaneous head and neck sccs and risk of nodal metastasis.uk experience. J Craniomaxillofac Surg, 37, 443-7. https://doi.org/10.1016/j.jcms.2009.07.007
  20. Ondruschka C, Buhtz P, Motsch C, et al (2002). Prognostic value of MMP-2,-9 and TIMP-1,-2 immunoreactive protein at the invasive front in advanced head and neck squamous cell carcinomas. Pathol Res Pract, 198, 509-15. https://doi.org/10.1078/S0344-0338(04)70292-7
  21. Patel V, Ramesh A, Traicoff JL, et al (2005). Profiling egfr activity in head and neck squamous cell carcinoma by using a novel layered membrane western blot technology. Oral Oncol, 41, 503-8. https://doi.org/10.1016/j.oraloncology.2004.12.010
  22. Pei L, Melmed S (1997). Isolation and characterization of a pituitary tumor-transforming gene (pttg). Mol Endocrinol, 11, 433-41. https://doi.org/10.1210/mend.11.4.9911
  23. Roy R, Yang J, Moses MA (2009). Matrix metalloproteinases as novel biomarker s and potential therapeutic targets in human cancer. J Clin Oncol, 27, 5287-97. https://doi.org/10.1200/JCO.2009.23.5556
  24. Shibata Y, Haruki N, Kuwabara Y, et al (2002). Expression of pttg (pituitary tumor transforming gene) in esophageal cancer. Jpn J Clin Oncol, 32, 233-7. https://doi.org/10.1093/jjco/hyf058
  25. Solbach C, Roller M, Fellbaum C, et al (2004). PTTG mRNA expression in primary breast cancer: A prognostic marker for lymph node invasion and tumor recurrence. Breast, 13, 80-1. https://doi.org/10.1016/j.breast.2003.09.008
  26. Urba W, Washington C, Nadiminti H (2012). Cancer of the Skin. In: Harrison's Principles of Internal Medicine (18th Edition) (Longo DL, Hause SL, Jameson JL and Loscalzo, eds.). McGraw-Hill Medical Publishing Division, New York.
  27. Woodhouse EC, Chuaqui RF, Liotta LA (1997). General mechanisms of metastasis. Cancer, 80, 1529-37. https://doi.org/10.1002/(SICI)1097-0142(19971015)80:8+<1529::AID-CNCR2>3.0.CO;2-F
  28. Zhang X, Horwitz GA, Heaney AP, et al (1999). Pituitary tumor transforming gene (PTTG) expression in pituitary adenomas. J Clin Endocrinol Metab, 84, 761-7. https://doi.org/10.1210/jcem.84.2.5432

피인용 문헌

  1. Metabolomics Investigation of Cutaneous T Cell Lymphoma Based on UHPLC-QTOF/MS vol.15, pp.13, 2014, https://doi.org/10.7314/APJCP.2014.15.13.5417
  2. Systematical Analysis of Cutaneous Squamous Cell Carcinoma Network of microRNAs, Transcription Factors, and Target and Host Genes vol.15, pp.23, 2014, https://doi.org/10.7314/APJCP.2014.15.23.10355
  3. Securin promotes migration and invasion via matrix metalloproteinases in glioma cells pp.1792-1082, 2015, https://doi.org/10.3892/ol.2015.3074
  4. Role of Matrix Metalloproteinases in Photoaging and Photocarcinogenesis vol.17, pp.6, 2016, https://doi.org/10.3390/ijms17060868